Clinical Trials · NCT06772532
A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 30
- Start date
- Feb 2025
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz)